Polymethoxylated Flavones Target Cancer Stemness and Improve the Antiproliferative Effect of 5-Fluorouracil in a 3D Cell Model of Colorectal Cancer
Authors:
- Carolina V. PereiraCPCarolina V. Pereira
- Marlene DuarteMDMarlene Duarte
- Patrícia SilvaPSPatrícia Silva
- Andreia Bento da SilvaASAndreia Bento da Silva
- Catarina M. M. DuarteCDCatarina M. M. Duarte
- Alejandro CifuentesAlejandro Cifuentes
- Virginia García-CañasVirginia García-Cañas
- Maria R. BronzeMBMaria R. Bronze
- Cristina AlbuquerqueCACristina Albuquerque
- Ana Teresa SerraASAna Teresa Serra
Open Access
Abstract
Polymethoxylated flavones (PMFs) from citrus fruits are reported to present anticancer potential. However, there is a lack of information regarding their effect on cancer stem cell (CSC) populations, which has been recognized as responsible for tumor initiation, relapse, and chemoresistance. In this study, we evaluated the effect of an orange peel extract (OPE) and its main PMFs, namely, nobiletin, sinensetin, tangeretin, and scutellarein tetramethylether in targeting cell proliferation and stemness using a 3D cell model of colorectal cancer composed of HT29 cell spheroids cultured for 7 days in stirred conditions. Soft agar assay, ALDH1 activity, and relative quantitative gene expression analysis of specific biomarkers were carried out to characterize the stemness, self-renewal, and mesenchymal features of HT29 cell spheroids. Then, the impact of OPE and PMFs in reducing cell proliferation and modulating cancer stemness and self-renewal was assessed. Results showed that, when compared with monolayer cultures, HT29 cell spheroids presented higher ALDH1 activity (81.97% ± 5.27% compared to 63.55% ± 17.49% for 2D), upregulation of CD44, PROM1, SOX9, and SNAI1 genes (1.83 ± 0.34, 2.54 ± 0.51, 2.03 ± 0.15, and 6.12 ± 1.59 times) and high self-renewal capability (352 ± 55 colonies compared to 253 ± 42 for 2D). Incubation with OPE (1 mg/mL) significantly inhibited cell proliferation and modulated cancer stemness and self-renewal ability: colony formation, ALDH1 activity, and the expression of cancer stemness biomarkers PROM1 and LGR5 were significantly reduced (0.66 ± 0.15 and 0.51 ± 0.14 times, respectively). Among all PMFs, tangeretin was the most efficient in targeting the CSC population by decreasing colony formation and the expression of PROM1 and LGR5. Scutellarein tetramethylether was shown to modulate markers of mesenchymal/metastatic transition (increasing CDH1 and reducing ZEB1 and SNAI1) and nobiletin was capable of downregulating PROM1 and SNAI1 expression. Importantly, all PMFs and OPE were shown to synergistically interact with 5-fluorouracil, improving the antiproliferative response of this drug.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (iNOVA4Health - UID/Multi/04462/2013)
This publication has 65 references indexed in Scilit:
- Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling PathwaysPLOS ONE, 2013
- Chemotherapy and Dietary Phytochemical AgentsChemotherapy Research and Practice, 2012
- Prognostic role of CD133 expression in colorectal cancer: a meta-analysisBMC Cancer, 2012
- Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthaseBreast Cancer Research and Treatment, 2010
- Curcumin enhances dasatinib‐induced inhibition of growth and transformation of colon cancer cellsInternational Journal of Cancer, 2010
- Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem CellsClinical Cancer Research, 2010
- Cancer stem cells from colorectal cancer-derived cell linesProceedings of the National Academy of Sciences, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon TumorigenesisCancer Research, 2009
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences, 2007